TB-500 Fragment 17-23 5mg

TB-500 Fragment 17-23 5mg – Actin-Modulating Research Peptide Fragment

FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION.

Scientific Background

TB-500 Fragment 17-23 is a short peptide fragment derived from thymosin beta-4 (TB-4) and is
under investigation in laboratory settings related to cytoskeletal dynamics. In research models, TB-4–related
sequences are commonly explored for potential interactions with actin-regulation pathways and for use in
studying cell migration, tissue remodeling signaling, and related in-vitro assay systems.

Specification

• Peptide Name: TB-500 Fragment 17-23 (TB-4 Fragment 17-23)
• Content: 5mg lyophilized powder (requires reconstitution)
• Purity: ≥ 99% (HPLC / MS certificate available)
• Manufacturing: ISO 9001:2015 & cGMP-audited facility
• Intended Use: In-vitro laboratory research only

Storage & Handling

• Prior to reconstitution: store ≤ 8 °C in a dry environment
• After reconstitution: refrigerate 2 – 8 °C and use within 30 days
• For extended preservation: aliquot and freeze at −20 °C
• Avoid repeated freeze–thaw cycles

Compliance Notice

Supplied exclusively to qualified professionals for controlled laboratory applications. No dosage or
administration guidance is provided. Buyer assumes responsibility for safe handling and regulatory adherence.